Regular Insulin (Human) Injectable bulk supplier for pharma manufacturers

Regular Insulin (Human) Injectable U-100 (100 units/mL) Suppliers & Bulk Manufacturers

Available Forms: Vials/pens

Available Strengths: U-100 (100 units/mL)

Reference Brands: Humulin R, Novolin R, Admelog R(US); Actrapid, Humulin R, Monotard R(EU)

Category: Diabetes

Regular Insulin (Human) works by mimicking natural insulin to regulate blood glucose levels, reducing hyperglycemia in diabetics. Its benefits include rapid blood sugar control, predictable action, and widespread availability, making it essential for managing both type 1 and type 2 diabetes effectively.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Regulatory approval for Regular Insulin (Human) in the EU and US ensures safety, efficacy, and quality. In the EU, brands like Actrapid and Humulin R are approved by EMA, including biosimilars that enhance access. In the US, FDA-approved options include Humulin R, Novolin R, and biosimilars such as Admelog R. Both regions require comprehensive dossiers demonstrating biosimilarity, manufacturing standards, and post-marketing surveillance to maintain high-quality standards. For detailed information on regulatory processes, visit PharmaTradz, your trusted source for pharmaceutical dossier support and compliance solutions.

Regular Insulin (Human) Injectable — third party manufacturing & bulk supply

Regular Insulin (Human) Injectable U-100 (100 units/mL) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Regular Insulin (Human) Injectable is supplied as Vials/pens — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Regular Insulin (Human) Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Regular Insulin (Human) Injectable →

Back to Listing

Frequently Asked Questions

Regular Insulin (Human) Injectable is listed as Vials/pens in U-100 (100 units/mL). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Regular Insulin (Human) Injectable is referenced against Humulin R, Novolin R, Admelog R(US); Actrapid, Humulin R, Monotard R(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.